The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia

Clinical trial NCT07390240 · RECRUITING

Trial details

NCT number: NCT07390240
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Hypophosphatasia

Start date: 2025-12-29
Primary completion: 2027-06-30
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.